- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02758028
Helping Youth Smokers Stop Smoking Through the Youth Quitline Programme
The aims of the present study are:
- To raise the awareness of smoking cessation service among youth smokers in Hong Kong;
- To provide smoking cessation quitline service to youth smokers; and
- To provide training to teenagers as peer smoking cessation counsellors.
- To examine the effectiveness of adventure-based training and WhatsApp messages in helping youth smokers to quit
Study Overview
Detailed Description
In Hong Kong, the demand of smoking cessation service of Youth was increasing in the past 10 years, the first youth-oriented smoking cessation hotline "Youth Quitline" was established in 2005. From August 2005 to July 2016, "Youth Quitline" has received over 9,267 telephone inquiries and provided telephone smoking cessation counselling for 1,952 youth smokers.
Youth smokers are recruited using the reactive and proactive strategies. The operation hours of Quitline service are weekdays from 17:00 to 21:00 and on weekends from 14:00 to 20:00. A questionnaire asking the smoking status, reason of smoking, dependency level, knowledge, attitude and practice of smoking or quitting at baseline, the perceived barriers of the smokers and the use of other tobacco products were designed to assess the status of participants, brief counselling with the use of motivational intervention approach is delivered during the phone call.
Telephone counseling at 1-week, 1-month, 3-month, 6-month, 9-month, 12-month and follow-up at 24-month are conducted with the participants to assess their smoking status (by questionnaire) and reinforce intervention (encourage quitting and providing quitting tips). Self-reported quitters who have quitted smoking for at least 7 days at 6-month are invited to perform saliva cotinine test (using NicAlert strip) plus exhaled carbon monoxide text to validate the smoking status.
A qualitative interview will be conducted to investigate the use of other tobacco products of the Youth Quitline participants, and aimed to find out their smoking patterns and feelings of using these products, and how these products might affect quitting or smoking, and how the protest activates influence the smoking behaviors among the youth smokers.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, China
- Recruiting
- The University of Hong Kong
-
Contact:
- William Li, PhD
- Phone Number: 852-39176634
- Email: william3@hku.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Hong Kong resident aged 25 or below
- Able to communicate in Chinese (Cantonese)
- Smoked in the past 30 days
Exclusion Criteria:
- Have difficulty to communicate via telephone
- Having queries irrelevant to tobacco control
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Brief counseling
Peer counselling is delivered based on the queries and the needs of individual clients, according to the smoking status, dependency level and the perceived barriers of each individual with the use of motivational intervention approach. Counsellors will emphasizes the identification, use, and modification of personally relevant coping strategies. Advice will be provided on overcoming expected difficulty, withdrawal symptoms and relapse prevention during quitting. The subjects will be followed up at 1-week, 1-, 3-, 6-, 9-, 12- and 24-month via telephone assessing their smoking status and reinforce intervention. |
Peer counselling is delivered based on the queries and the needs of individual clients, according to the smoking status, dependency level and the perceived barriers of each individual with the use of motivational intervention approach. The subjects will be followed up at 1-week, 1-, 3-, 6-, 9-, 12- and 24-month via telephone assessing their smoking status and reinforce intervention. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
7-days point prevalence smoking abstinence at 6-month
Time Frame: 6-month follow-up
|
7-days point prevalence smoking abstinence is measured at 6-month.
A questionnaire asking smoking status, quitting experience and difficulty in quitting was designed to assess the self-reported smoking abstinence at 6-month.
|
6-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bio-chemical validated smoking abstinence at 6-month
Time Frame: 6-month follow-up
|
Bio-chemical validated smoking abstinence is measured at 6-month.
The participants who claim to have quitted smoking for at least 7 days are invited for biochemical validation (measurement of saliva cotinine level and exhaled carbon monoxide level) at 6-month.
The participants are need to get the results of CO≤ 4ppm, and continine level ≤30 ng/ml as passing results.
|
6-month follow-up
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- YouthQuitline
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.